MIST — MILESTONE PHARMACEUTICALS IN
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 80 家机构在其最新 13F 申报中持有 MIST(MILESTONE PHARMACEUTICALS IN),合计申报市值 $69.63M,对应 51.96M 股。按股数计算较上季度增持 34.1%(+12.66M 股),申报市值环比上升 50.3%。持仓集中度较高:前五大持有人占申报市值的 63.7%,前十大的集中度为 85.6%。
与上一季度相比,8 家新建仓位、22 家加仓、24 家减仓、14 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
MILESTONE PHARMACEUTICALS IN(MIST)的主要机构持有人包括 RTW INVESTMENTS, LP、BlackRock Inc、Propel Bio Management, LLC,按 13F 申报市值在本页 142 家持有人中排名居前。
MIST 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 51 | 28.89M | $25.01M | +9.5% |
| Q2 2026 | 80 | 51.96M | $69.63M | +34.1% |
| Q1 2026 | 86 | 39.58M | $47.28M | +25.2% |
| Q4 2025 | 81 | 33.26M | $67.22M | -20.1% |
| Q3 2025 | 62 | 33.22M | $66.44M | +93.8% |
| Q2 2025 | 44 | 11.77M | $22.82M | +5.0% |
| Q1 2025 | 46 | 12.10M | $9.68M | -46.1% |
| Q4 2024 | 46 | 26.61M | $62.81M | -11.5% |
表内 8 个季度中,机构持股合计增加 9%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+93.8%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.45M | $8.18M | 4.34% | 增持 | |
| 9.34M | $8.08M | 3.38% | 增持 | |
| 3.35M | $2.90M | 0.05% | 持有 | |
| 1.65M | $1.43M | 1.08% | 增持 | |
| 1.15M | $994.05K | 0.06% | 新进 | |
| 1.12M | $972.35K | 0.00% | 减持 | |
| 617.85K | $534.87K | 0.00% | 减持 | |
| 465.24K | $402.90K | 0.00% | 持有 | |
| 405.00K | $350.61K | 0.00% | 增持 | |
| 274.63K | $237.75K | 0.00% | 增持 | |
| 159.50K | $138.08K | 0.00% | 增持 | |
| 146.70K | $127.00K | 0.00% | 增持 | |
| 110.92K | $96.02K | 0.00% | 减持 | |
| 79.07K | $68.45K | 0.01% | 新进 | |
| 66.53K | $57.00K | 0.00% | 新进 | |
| 40.00K | $34.63K | 0.04% | 持有 | |
| 36.00K | $31.16K | 0.00% | 持有 | |
| 27.83K | $24.09K | 0.00% | 持有 | |
| 27.24K | $23.58K | 0.00% | 增持 | |
| 26.60K | $23.03K | 0.00% | 减持 | |
| 25.00K | $21.64K | 0.00% | 持有 | |
| 22.69K | $19.64K | 0.01% | 持有 | |
| 20.00K | $17.31K | 0.01% | 持有 | |
| 20.00K | $17.31K | 0.01% | 持有 | |
| 18.88K | $16.34K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.07M | $12.15M | 5.47% | 持有 | |
| 7.83M | $10.50M | 0.09% | 增持 | |
| 7.43M | $9.96M | 5.21% | 增持 | |
| 5.41M | $7.25M | 0.03% | 增持 | |
| 3.35M | $4.49M | 0.06% | 增持 | |
| 3.14M | $4.21M | 0.00% | 增持 | |
| 3.14M | $4.21M | 0.01% | 增持 | |
| 2.04M | $2.73M | 0.00% | 减持 | |
| 1.80M | $2.41M | 0.00% | 减持 | |
| 1.27M | $1.70M | 0.98% | 新进 | |
| 820.00K | $1.10M | 5.26% | 持有 | |
| 750.00K | $1.00M | 0.00% | 持有 | |
| 666.67K | $893.33K | 0.00% | 新进 | |
| 666.67K | $893.33K | 0.07% | 持有 | |
| 635.21K | $851.18K | 0.00% | 减持 | |
| 465.40K | $623.64K | 0.00% | 减持 | |
| 462.67K | $619.98K | 0.01% | 增持 | |
| 339.45K | $454.86K | 0.03% | 增持 | |
| 270.23K | $362.11K | 0.06% | 减持 | |
| 231.82K | $310.64K | 0.00% | 减持 | |
| 220.87K | $295.97K | 0.00% | 增持 | |
| 220.50K | $295.47K | 0.00% | 减持 | |
| 173.70K | $232.76K | 0.00% | 减持 | |
| 150.00K | $201.00K | 0.11% | 增持 | |
| 140.63K | $188.44K | 0.00% | 增持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.06M | $10.78M | 5.93% | 增持 | |
| 6.33M | $7.53M | 0.07% | 增持 | |
| 4.12M | $5.08M | 3.20% | 持有 | |
| 2.32M | $2.76M | 0.00% | 增持 | |
| 2.00M | $2.38M | 0.00% | 新进 | |
| 1.94M | $2.31M | 0.00% | 增持 | |
| 1.54M | $1.84M | 0.00% | 增持 | |
| 1.54M | $1.84M | 0.00% | 增持 | |
| 1.51M | $1.79M | 0.03% | 持有 | |
| 1.09M | $1.29M | 0.01% | 增持 | |
| 851.33K | $1.01M | 0.00% | 新进 | |
| 820.00K | $975.80K | 5.83% | 增持 | |
| 750.00K | $892.50K | 0.00% | 持有 | |
| 724.14K | $861.73K | 0.00% | 减持 | |
| 666.67K | $793.33K | 0.10% | 持有 | |
| 494.91K | $588.94K | 0.00% | 增持 | |
| 336.82K | $400.82K | 0.00% | 增持 | |
| 333.33K | $396.67K | 0.27% | 新进 | |
| 280.25K | $333.50K | 0.00% | 增持 | |
| 280.25K | $333.50K | 0.02% | 增持 | |
| 193.37K | $230.11K | 0.00% | 增持 | |
| 176.50K | $210.04K | 0.00% | 减持 | |
| 168.68K | $200.72K | 0.01% | 新进 | |
| 149.10K | $177.44K | 0.00% | 新进 | |
| 130.70K | $155.53K | 0.01% | 持有 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.50M | $17.17M | 9.69% | 新进 | |
| 4.12M | $8.32M | 7.10% | 减持 | |
| 2.81M | $5.68M | 0.01% | 减持 | |
| 2.51M | $5.06M | 0.05% | 持有 | |
| 1.66M | $3.35M | 0.01% | 增持 | |
| 1.51M | $3.06M | 0.01% | 增持 | |
| 1.51M | $3.04M | 0.05% | 减持 | |
| 1.02M | $2.10M | 0.01% | 增持 | |
| 781.88K | $1.58M | 0.00% | 减持 | |
| 755.00K | $1.53M | 7.89% | 增持 | |
| 750.00K | $1.51M | 0.01% | 持有 | |
| 666.67K | $1.35M | 0.29% | 持有 | |
| 662.67K | $1.34M | 1.03% | 新进 | |
| 619.59K | $1.25M | 0.00% | 增持 | |
| 491.87K | $993.57K | 0.00% | 增持 | |
| 482.36K | $974.36K | 0.00% | 新进 | |
| 402.63K | $813.32K | 0.00% | 持有 | |
| 402.63K | $813.32K | 0.00% | 持有 | |
| 263.20K | $531.66K | 0.01% | 增持 | |
| 263.20K | $531.66K | 0.04% | 增持 | |
| 249.34K | $503.68K | 0.00% | 新进 | |
| 236.14K | $477.00K | 0.04% | 增持 | |
| 225.00K | $454.50K | 0.00% | 新进 | |
| 221.95K | $448.34K | 0.00% | 新进 | |
| 171.96K | $347.36K | 0.01% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.98M | $13.95M | 0.02% | 新进 | |
| 5.12M | $10.25M | 10.26% | 增持 | |
| 3.22M | $6.44M | 0.17% | 新进 | |
| 2.97M | $5.94M | 0.00% | 增持 | |
| 2.83M | $5.67M | 0.10% | 增持 | |
| 2.51M | $5.01M | 0.06% | 持有 | |
| 1.00M | $2.00M | 0.01% | 新进 | |
| 820.00K | $1.64M | 0.38% | 新进 | |
| 750.00K | $1.50M | 0.01% | 持有 | |
| 666.67K | $1.33M | 0.13% | 新进 | |
| 666.67K | $1.33M | 0.42% | 新进 | |
| 666.55K | $1.33M | 0.00% | 新进 | |
| 658.55K | $1.32M | 7.48% | 增持 | |
| 425.03K | $850.06K | 0.00% | 新进 | |
| 401.56K | $803.12K | 0.00% | 新进 | |
| 401.56K | $803.12K | 0.00% | 新进 | |
| 397.53K | $795.07K | 0.00% | 增持 | |
| 356.57K | $713.13K | 0.00% | 增持 | |
| 234.04K | $468.08K | 0.00% | 新进 | |
| 223.47K | $448.06K | 0.01% | 新进 | |
| 210.20K | $420.40K | 0.00% | 新进 | |
| 210.20K | $420.40K | 0.03% | 新进 | |
| 187.30K | $374.60K | 0.02% | 增持 | |
| 143.40K | $287.00K | 0.00% | 增持 | |
| 138.81K | $277.00K | 0.00% | 新进 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.51M | $4.86M | 0.07% | 持有 | |
| 1.79M | $3.48M | 4.24% | 增持 | |
| 1.40M | $2.71M | 1.48% | 减持 | |
| 1.14M | $2.20M | 1.67% | 持有 | |
| 990.00K | $1.92M | 0.10% | 增持 | |
| 820.42K | $1.59M | 0.00% | 减持 | |
| 750.00K | $1.46M | 0.01% | 持有 | |
| 548.81K | $1.06M | 7.23% | 持有 | |
| 500.00K | $970.00K | 0.24% | 持有 | |
| 322.65K | $625.94K | 0.00% | 增持 | |
| 160.96K | $312.27K | 0.01% | 增持 | |
| 130.70K | $253.56K | 0.01% | 增持 | |
| 119.45K | $231.73K | 0.00% | 新进 | |
| 67.14K | $130.24K | 0.07% | 新进 | |
| 53.00K | $102.82K | 0.00% | 持有 | |
| 43.23K | $83.88K | 0.00% | 增持 | |
| 36.00K | $69.84K | 0.00% | 新进 | |
| 35.60K | $69.00K | 0.00% | 增持 | |
| 31.93K | $61.95K | 0.00% | 新进 | |
| 25.04K | $48.59K | 0.01% | 持有 | |
| 23.41K | $45.41K | 0.00% | 增持 | |
| 19.80K | $38.41K | 0.00% | 减持 | |
| 19.06K | $36.98K | 0.01% | 减持 | |
| 18.70K | $36.09K | 0.00% | 持有 | |
| 18.25K | $35.40K | 0.00% | 减持 |
新建仓(Q2 2026)
- Kalehua Capital Management LLC 1.27M 股 · $1.70M
- AMERIPRISE FINANCIAL INC 666.67K 股 · $893.33K
- Cascades Capital Asset Management, LLC 83.61K 股 · $112.04K
- GEODE CAPITAL MANAGEMENT, LLC 40.79K 股 · $54.66K
- TWO SIGMA SECURITIES, LLC 16.75K 股 · $22.44K
- WINTON GROUP Ltd 14.30K 股 · $19.16K
- Virtu Financial LLC 11.61K 股 · $16.00K
- Arax Advisory Partners 3.05K 股 · $4.09K
完全清仓(较上季)
- Goldman Sachs Group 卖出 2.00M 股 · $2.38M
- Renaissance Technologies 卖出 129.71K 股 · $154.35K
- HRT FINANCIAL LP 卖出 62.26K 股 · $74.00K
- Invesco Ltd 卖出 41.36K 股 · $49.21K
- Northern Trust Corp 卖出 38.78K 股 · $46.15K
- GSA CAPITAL PARTNERS LLP 卖出 26.89K 股 · $32.00K
- STATE STREET CORP 卖出 22.33K 股 · $26.57K
- JOURNEY STRATEGIC WEALTH LLC 卖出 20.00K 股 · $23.80K
- SJS Investment Consulting Inc. 卖出 15.00K 股 · $17.85K
- Bayesian Capital Management, LP 卖出 10.02K 股 · $11.92K
- Ancora Advisors LLC 卖出 10.00K 股 · $11.90K
- CWM, LLC 卖出 10.00K 股 · $11.90K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Propel Bio Management, LLC | 9.45M | 7.43M | 4.12M | 4.12M | 5.12M | 1.79M | 1.45M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pavaki Capital Management LLC | 9.34M | 9.07M | 9.06M | 8.50M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Simplify Asset Management Inc. | 3.35M | 3.35M | 1.51M | 1.51M | 2.83M | 990.00K | 850.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 1.65M | 1.27M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| RVW Wealth, LLC | 1.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 1.12M | 1.80M | 1.94M | 1.66M | 425.03K | — | — | — | — | — | — | — | 113.19K | 167.10K | 232.49K | 421.54K | 30.90K | — | — | — |
| Morgan Stanley | 617.85K | 635.21K | 724.14K | 781.88K | 2.97M | 820.42K | 968.52K | 1.29M | 918.31K | 828.65K | 819.83K | 689.40K | 700.62K | 805.04K | 837.86K | 1.33M | 1.24M | 1.32M | 818.64K | 826.00K |
| UBS Group AG | 465.24K | 465.40K | 494.91K | 491.87K | 397.53K | 322.65K | 111.52K | 89.51K | — | — | 2.62K | — | 1.69K | 3.34K | 2.77K | 5.18K | 3.32K | 1.02K | — | 1.03K |
| Aptus Capital Advisors, LLC | 405.00K | 500 | 280.25K | 263.20K | 210.20K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| LPL Financial LLC | 274.63K | 220.87K | 193.37K | 142.46K | 95.30K | 11.05K | 111.54K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wealthspire Advisors, LLC | 159.50K | 140.63K | 10.63K | — | 1.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Valeo Financial Advisors, LLC | 146.70K | 130.70K | 130.70K | 130.70K | 130.70K | 130.70K | 20.00K | 20.00K | 20.00K | 10.00K | 10.00K | 10.00K | 120.70K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 110.92K | 173.70K | 176.50K | 221.95K | — | — | 26.02K | 31.13K | 29.21K | 24.60K | 16.90K | 6.10K | 2.10K | — | — | — | — | — | — | — |
| Pinnacle Wealth Planning Services, Inc. | 79.07K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 66.53K | — | 62.26K | — | 138.81K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| October Effect Ltd | 40.00K | 40.00K | 51.95K | 52.10K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Focus Partners Wealth | 36.00K | 36.00K | 36.00K | 36.00K | 36.00K | 36.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Mariner, LLC | 27.83K | 27.83K | 30.83K | 25.00K | 25.00K | 11.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 27.24K | — | 22.33K | 21.88K | 22.22K | 18.25K | 18.54K | 19.12K | 19.31K | 18.92K | 18.92K | 21.61K | 21.61K | — | — | — | — | — | — | — |
| RAYMOND JAMES FINANCIAL INC | 26.60K | 30.07K | 26.60K | 26.60K | 26.60K | 43.23K | 33.23K | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold MIST?
As of 2026-Q2, 80 institutional funds reported holding MIST (MILESTONE PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $69.63M.
How many shares of MIST do institutions own?
13F filers reported 51.96M shares of MIST, worth $69.63M in aggregate at the end of 2026-Q2.
Is institutional ownership of MIST rising or falling?
Share counts moved +34.1% versus the prior quarter — accumulation.
Who are the top institutional holders of MIST?
The largest 13F holders are RTW INVESTMENTS, LP, BlackRock Inc, Propel Bio Management, LLC, Pavaki Capital Management LLC, Point72 Asset Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of MILESTONE PHARMACEUTICALS IN?
The major shareholders of MILESTONE PHARMACEUTICALS IN (MIST) by reported 13F value are RTW INVESTMENTS, LP, BlackRock Inc, Propel Bio Management, LLC, Pavaki Capital Management LLC, Point72 Asset Management, among 142 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.